Potential Therapeutic Agents Against Retinal Diseases Caused by Aberrant Metabolism of Retinoids

Invest Ophthalmol Vis Sci. 2016 Mar;57(3):1017-30. doi: 10.1167/iovs.15-18429.

Abstract

The retinoid (visual) cycle is a complex enzymatic pathway that operates in the retina for the regeneration of 11-cis-retinal (11-cis-Ral), the inherent visual chromophore indispensable for vision. Deficiencies in the retinoid metabolism are involved in pathologic mechanisms of several forms of retinal diseases including age-related macular degeneration, Stargardt's disease, and Leber's congenital amaurosis, for which no effective cures presently exist. Nevertheless, the interference of abnormal retinoid metabolism with chemicals has been considered to be a promising strategy aimed at alleviating these retinal dysfunctions. Moreover, since gene therapy is gaining increasing importance in clinical practice, the modulation of key enzymes implicated with the retinoid cycle at a genetic level will hold great promise for the treatment of patients with degenerative diseases of the retina.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Genetic Therapy / methods*
  • Humans
  • Retina / metabolism*
  • Retinal Diseases* / chemically induced
  • Retinal Diseases* / etiology
  • Retinal Diseases* / metabolism
  • Retinal Diseases* / therapy
  • Retinoids / adverse effects
  • Retinoids / metabolism*
  • Retinoids / pharmacokinetics

Substances

  • Retinoids